SAM #D-26-DA-0021

This opportunity involves the DEA's procurement of broadcast advertising services for the Fentanyl Free America campaign: - Sole source purchase order to Nexstar Media, Inc. (CW33 affiliate) - Nexstar Media holds exclusive broadcast rights for Texas Rangers MLB games in the Dallas Federal District Area - Services requested: - Pre-game ad displays - 30 and 15 second public service announcements during Texas Rangers MLB game broadcasts - No specific product part numbers or quantities provided - Procurement is exempt from full and open competition under 13.501 - NAICS code: 516120 (Television Broadcasting) - Period of performance: March 29, 2026 – May 26, 2026 (approx. 2 months) - Place of performance: Dallas Federal District Area of Responsibility (Dallas, TX 75220) - Unique requirements: - Sole source justification due to exclusive broadcast rights - Focused on public service announcements for fentanyl awareness

The Drug Enforcement Administration (DEA) requires pre-game ad displays during pre-game. The DEA intends to award a firm-fixed price sole source Purchase Order to Nexstar Media, Inc., 545 E. John Carpenter Fwy Ste 700, Irving, TX for the purposes of the Fentanyl Free America campaign. This acquisition is being pursued on a sole source basis in accordance with 13.501 are exempt from the requirement to promote full and open competition. The NAICS code for this acquisition is 516120. A determination by the Government not to open the requirement to competition based on the response to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice is NOT a request for proposal. However, all capability statements received by March 30, 2026 at 9:00 a.m. EST will be considered by the Government. Any source capable of providing the pregame ad displays during pre-game, and is interested in submiting a capabilities statement may do so electronically to Ms. Angel Barkley at angel.d.barkley@dea.gov.